Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Claudia Basilico"'
Autor:
Giuseppe Rossi, Erika Borlenghi, Patrizia Zappasodi, Federico Lussana, Massimo Bernardi, Claudia Basilico, Alfredo Molteni, Ivana Lotesoriere, Mauro Turrini, Marco Frigeni, Monica Fumagalli, Paola Cozzi, Federica Gigli, Chiara Cattaneo, Nicola Stefano Fracchiolla, Marta Riva, Gianluca Martini, Valentina Mancini, Roberto Cairoli, Elisabetta Todisco
Publikováno v:
Cancers, Vol 16, Iss 2, p 386 (2024)
A retrospective survey was conducted in hematologic centres of the Rete Ematologica Lombarda (REL) on 529 older AML patients seen between 2020–2022. Compared to 2008–2016, the use of intensive chemotherapy (ICT) decreased from 40% to 18.1% and of
Externí odkaz:
https://doaj.org/article/3c6e55c9a0f04235961e71dd944aa064
Autor:
Luana Fianchi, Fabio Guolo, Francesco Marchesi, Chiara Cattaneo, Michele Gottardi, Francesco Restuccia, Anna Candoni, Elettra Ortu La Barbera, Rita Fazzi, Crescenza Pasciolla, Olimpia Finizio, Nicola Fracchiolla, Mario Delia, Federica Lessi, Michelina Dargenio, Valentina Bonuomo, Maria Ilaria Del Principe, Patrizia Zappasodi, Marco Picardi, Claudia Basilico, Monica Piedimonte, Paola Minetto, Antonio Giordano, Patrizia Chiusolo, Lucia Prezioso, Caterina Buquicchio, Lorella Maria Antonia Melillo, Daniele Zama, Francesca Farina, Valentina Mancini, Irene Terrenato, Michela Rondoni, Irene Urbino, Mario Tumbarello, Alessandro Busca, Livio Pagano
Publikováno v:
Cancers, Vol 15, Iss 13, p 3457 (2023)
In the present study, we aimed to evaluate the absolute risk of infection in the real-life setting of AML patients treated with CPX-351. The study included all patients with AML from 30 Italian hematology centers of the SEIFEM group who received CPX-
Externí odkaz:
https://doaj.org/article/ac8c0b9b85df4a1b9b5efffa7787c43a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pagano, Luana Fianchi, Fabio Guolo, Francesco Marchesi, Chiara Cattaneo, Michele Gottardi, Francesco Restuccia, Anna Candoni, Elettra Ortu La Barbera, Rita Fazzi, Crescenza Pasciolla, Olimpia Finizio, Nicola Fracchiolla, Mario Delia, Federica Lessi, Michelina Dargenio, Valentina Bonuomo, Maria Ilaria Del Principe, Patrizia Zappasodi, Marco Picardi, Claudia Basilico, Monica Piedimonte, Paola Minetto, Antonio Giordano, Patrizia Chiusolo, Lucia Prezioso, Caterina Buquicchio, Lorella Maria Antonia Melillo, Daniele Zama, Francesca Farina, Valentina Mancini, Irene Terrenato, Michela Rondoni, Irene Urbino, Mario Tumbarello, Alessandro Busca, Livio
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3457
In the present study, we aimed to evaluate the absolute risk of infection in the real-life setting of AML patients treated with CPX-351. The study included all patients with AML from 30 Italian hematology centers of the SEIFEM group who received CPX-
Autor:
Chiara Pagani, Erika Borlenghi, Matteo Claudio Da Via, Chiara Cattaneo, Fabio Ciceri, Roberto Cairoli, Francesco Passamonti, Massimo Bernardi, Claudia Basilico, Nicola Stefano Fracchiolla, Valentina Mancini, Mauro Turrini, Mariarita Sciumè, Elisabetta Todisco, Giuseppe Rossi, Patrizia Zappasodi, Elisa Cerqui, Margherita Sciumé
Publikováno v:
Journal of Geriatric Oncology. 12:550-556
Objectives: Treatment of older patients with acute myeloid leukemia (AML) is still controversial. To facilitate treatment decisions, the “fitness criteria” proposed by Ferrara et al. (Leukemia, 2013), including age > 75 years, performance status
Autor:
Roberto Cairoli, Arianna Gatti, Giovanni Grillo, Monica Fumagalli, Mauro Krampera, Patrizia Zappasodi, Erika Borlenghi, Elisabetta Todisco, Marta Ubezio, Massimo Bernardi, Alfredo Molteni, Claudia Basilico, Mauro Turrini, Rosa Greco, Valentina Mancini, Marta Riva, Beatrice De Marco, Marta Rachele Stefanucci, Bruno Brando, Silvio Marco Veronese, Alessandro Beghini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb820a06132d3333f1f65d7a973b487e
https://hdl.handle.net/10281/411280
https://hdl.handle.net/10281/411280
Autor:
Eros Di Bona, Margherita Sciumé, Monica Bocchia, Gianpaolo Nadali, Monica Fumagalli, Monica Crugnola, Carlotta Galeone, Marzia Defina, Alfredo Molteni, Daniela Lambertenghi Deliliers, Silvia Imbergamo, Emanuela Caizzi, Giuseppina Greco, Nicola Stefano Fracchiolla, Roberto Latagliata, Anna Sicuranza, Claudia Basilico, Carla Filì, Vincenzo Sammartano, Giuseppe Rossi, Francesco Rotondo, Mariagrazia Michieli, Enrico Capochiani, Claudio Pelucchi, Giulia Alunni, Barbara Scappini, Massimo Bernardi, Marta Riva, Francesco Mazziotta, Chiara Cattaneo, Marianna Rossi, Giulia Fontanelli, Erika Borlenghi, Anna Candoni, Michele Gottardi, Catia Bigazzi, Ugo Consoli, Renato Fanin, Federico Simonetti, Elisabetta Todisco, Michela Rondoni, Anna Ermacora
Publikováno v:
Hematological Oncology. 37:447-455
Despite widespread use of decitabine to treat acute myeloid leukaemia (AML), data on its effectiveness and safety in the real-world setting are scanty. Thus, to analyze the performance of decitabine in clinical practice, we pooled together patient-le
Autor:
Fabio Stagno, Flavio Mignone, Erika Borlenghi, Elena Maino, Cristina Papayannidis, Simona Soverini, Manuela Stulle, Annalisa Imovilli, Claudia Basilico, Sabina Russo, Claudio Fozza, Chiara Sartor, Stefania Stella, Michele Cavo, Mario Annunziata, Roberta Minari, Federica Sorà, Michele Baccarani, Caterina De Benedittis, Luana Bavaro, Margherita Martelli, Francesco Albano, Massimiliano Bonifacio, Giovanni Martinelli, Elisabetta Abruzzese, Sara Galimberti
Publikováno v:
British journal of haematologyReferences. 193(2)
BCR-ABL1 kinase domain mutation testing in tyrosine kinase inhibitor (TKI)-resistant Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukaemia (ALL) patients is routinely performed by Sanger sequencing (SS). Recently, next-generation seque
Autor:
Marcus Hentrich, Jordi Esteve, Matteo G. Della Porta, Mar Tormo, Sigrid Machherndl-Spandl, Ana Garrido, Sonia Matos, Annika Dufour, Olga Salamero, Jorge Sierra, Marta Pratcorona, Lisa Pleyer, Federico Lussana, Maria Carmo-Fonseca, Francesco Passamonti, Paola Fazi, Albertina Nunes, Sonja Heibl, Susana Vives, Christoph Sippel, Nicola Stefano Fracchiolla, Alfonso Piciocchi, Joana M. P. Desterro, Montserrat Arnan, Pamela Acha, Erica Travaglino, Aida Botelho de Sousa, Friedrich Stölzel, Maria Teresa Voso, Giulia Maggioni, Christian Thiede, Claudia Basilico, Cristina Astrid Tentori, Francesc Solé, Karsten Spiekermann, Marcos Lemos, Klaus H. Metzeler, Elisabetta Todisco, Bernhard Heilmeier, Jan Moritz Middeke, Marina Diaz, Valentina Mancini, David Gallardo
Publikováno v:
Blood. 136:30-31
Introduction. Mutations in genes encoding the metabolic enzymes isocitrate dehydrogenase (IDH) 1 and 2 are found in 10-20% of patients with acute myeloid leukemia (AML). Recently, IDH inhibitors have shown good clinical response in patient's refracto
Publikováno v:
Expert Opinion on Investigational Drugs. 26:367-373
The role of interleukin-6 (IL-6) in tumorigenesis and in particular in haematological malignancies is crucial. On the basis of the favourable results obtained in the subset of multicentric Castleman disease (MCD), Siltuximab, a chimeric, human-murine